Send to:

Choose Destination
See comment in PubMed Commons below
Nat Rev Drug Discov. 2006 Sep;5(9):723-9. Epub 2006 Aug 18.

Can open-source R&D reinvigorate drug research?

Author information

  • 1Bernard Munos is at Eli Lilly & Co., Lilly Corporate Center, 1085, Indianapolis, Indiana 46285, USA.


The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Write to the Help Desk